Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients
Clinical trial NCT06964815 · RECRUITING
Trial details
- NCT number
- NCT06964815
- Sponsor
- Istituto Oncologico Veneto IRCCS
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-12
- Primary completion
- 2027-10-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.